ANTARES PHARMA INC (ATRS)

Company Profile

Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. The company is headquartered in Ewing, New Jersey and currently employs 201 full-time employees. The firm is focused primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. The firm develops, manufactures, and commercializes, for itself or with partners, therapeutic products using its drug delivery systems. The firm products include XYOSTED (testosterone enanthate) injection, NOCDURNA (desmopressin acetate), OTREXUP (methotrexate) injection, Epinephrine Injection USP, Sumatriptan Injection USP, Makena Subcutaneous Auto Injector and Teriparatide Injection. Its testosterone enanthate injection product is indicated for testosterone replacement therapy (TRT) in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Its desmopressin acetate is used for the treatment of nocturia due to nocturnal polyuria (NP) in adults who awaken at least two times per night to urinate.

Company Info

ANTARES PHARMA INC

100 Princeton South, Suite 300

Ewing NEW JERSEY 08628

P: 16093593020.0

CEO: Robert F. Apple

Employees: 201

Website: https://www.antarespharma.com/